emergent logo.jpg
Emergent BioSolutions Announces Initiation of Pivotal Phase 3 Study Evaluating the Safety and Immunogenicity of Its Single-Dose Chikungunya Vaccine Candidate, CHIKV VLP
15 oct. 2021 06h30 HE | Emergent BioSolutions
GAITHERSBURG, Md., Oct. 15, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced the first participant dosed in its pivotal phase 3 study evaluating the safety and...
RenovaCare Establishes Leadership Position in Cell Isolation and Spray Technology with Newly Awarded U.S. Patent
14 oct. 2021 08h30 HE | RenovaCare, Inc.
SCOTTSDALE, Ariz., Oct. 14, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented cell therapy technologies for the regeneration of skin and tissues,...
VistaGen Therapeutics Expands Clinical Development of PH94B with Initiation of Phase 2A Trial in Adjustment Disorder
14 oct. 2021 08h00 HE | VistaGen Therapeutics, Inc.
Study Launches Phase 2A Clinical Program Designed to Explore PH94B’s Potential in Multiple Additional Anxiety Disorders Phase 2A Study in Adjustment Disorder to Run in Parallel with Ongoing Phase 3...
CNS Pharmaceuticals logo.png
CNS Pharmaceuticals Inc. Featured in Syndicated Broadcast Covering Dosing of First Patients in Its Berubicin Clinical Development Program for Glioblastoma Multiforme
11 oct. 2021 08h00 HE | CNS Pharmaceuticals, Inc.
LOS ANGELES, Oct. 11, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- CNS Pharmaceuticals Inc. (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for...
Graphical Research.jpg
Clinical Trial Management System Market Trends 2021 | North America, Europe, & APAC Industry Forecasts 2027: Graphical Research
11 oct. 2021 06h00 HE | Graphical Research
Pune, India, Oct. 11, 2021 (GLOBE NEWSWIRE) -- The global clinical trial management system market size is poised to observe substantial growth during the forecast period, as governments are...
Zenflow logo copy.png
Zenflow Launches Pivotal Clinical Trial of Minimally Invasive Spring® Treatment for Enlarged Prostate Symptoms
04 oct. 2021 12h00 HE | Zenflow
SOUTH SAN FRANCISCO, Calif., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Zenflow, Inc., a medical device company developing a minimally invasive treatment for enlarged prostate, or benign prostatic...
American Gene Technologies Appoints Dr. Marcus A. Conant as Special Advisor to the CEO
01 oct. 2021 13h25 HE | American Gene Technologies
ROCKVILLE, Md., Oct. 01, 2021 (GLOBE NEWSWIRE) -- American Gene Technologies (AGT) announces the appointment of Dr. Marcus A. Conant, a leading dermatologist in the U.S. and one of the first...
Actipulse Neuroscience Announces Successful Clinical Trial Using Fast Gamma Magnetic Stimulation for the Treatment of Alzheimer's Disease
30 sept. 2021 15h00 HE | Actipulse Neuroscience
BOSTON, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Today, the results of a recent pilot clinical trial, funded by neurotech company Actipulse Neuroscience, have demonstrated that its non-invasive...
InMed Pharmaceuticals Inc..jpg
InMed Pharmaceuticals Announces Commencement of Phase 2 Clinical Trial Investigating Cannabinol (CBN), a Rare Cannabinoid, in the Treatment of Epidermolysis Bullosa
30 sept. 2021 07h30 HE | InMed Pharmaceuticals Inc.
VANCOUVER, British Columbia, Sept. 30, 2021 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the manufacturing and clinical development of rare...
Inventiva announces participation at several investor conferences in October 2021
28 sept. 2021 16h00 HE | INVENTIVA
Daix (France), Long Island City (New York, United States), September 28, 2021 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of...